Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Third Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy Adults
Sponsor: Kingdom
Summary
The goal of this clinical trial is to evaluate the performance of NOBO, a yeast-based fermentation product (postbiotic) designed to control axillary odor, in controlling axillary odor in healthy male and female adults age 18 - 70 with confirmed self-perception of body odor. The main question it aims to answer is: Does NOBO decrease self-perceived odor of the intervention axilla compared to the placebo axilla at any time point? Researchers will compare the intervention axilla odor score to the placebo axilla odor score to see if there is a difference in self-perceived odor. Participants will: * be given a NOBO deodorant spray and a placebo deodorant spray (each assigned to one axilla) * self assess body odor * self assess skin irritation
Official title: A Randomized, Double-Blind, Placebo-Controlled, Split-Axilla, Proof-of-Concept Study #3 to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy Adults
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2026-07-27
Completion Date
2026-07-31
Last Updated
2026-07-24
Healthy Volunteers
Yes
Conditions
Interventions
NOBO postbiotic
The active ingredient in the NOBO deodorant is a yeast-based fermentation product (postbiotic) of the Starmerella genus.
Placebo
The placebo deodorant is composed of 10% ethanol in water
Locations (1)
Kingdom
Brooklyn, New York, United States